It is mainly classified into two groups: isocitrate dehydrogenase (IDH)-wildtype GBM, which has been previously referred to as primary GBM and represents about 90% of cases, and IDH-mutant GBM, which is developed from a lower-grade diffuse glioma and represents about 10% of cases. This evidence concerns the gene IDH1 and glioblastoma.